| Janssen-Cilag AG - REKAMBYS 600 mg / 2 ml, Depot-Injektionssuspension |
| 67742 | | 01 | | REKAMBYS 600 mg / 2 ml | | Depot-Injektionssuspension | | J05AG05 | | Rilpivirine | | 08.10.2021 | | |
|
| Composition |
| rilpivirinum 600 mg, poloxamerum 338, glucosum monohydricum, natrii dihydrogenophosphas monohydricus, acidum citricum monohydricum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 2 ml corresp. natrium 1.66 mg. |
| Packungsbestandteile |
| Depot-Injektionssuspension | | | | | | Active Agent | Dose |
|---|
| Rilpivirinum | 600mg / 2ml |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Glucose Monohydrate | | | Sodium Dihydrogenophosphate Monohydrate | | | Sodium Hydroxide | | | Poloxamer | 338 |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | PR | PR | A | | Yes |
|
